Products for Research Use Only
RegisterLogin

Flanvotumab

CAT: 0804-HY-P99622-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99622-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) . Flanvotumab has potent anti-tumor activity and good tolerance[1].
CAS Number
1188277-05-5
Product Name Alternative
IMC-20D7S
UNSPSC
12352203
Target
Tyrosinase
Type
Inhibitory Antibodies
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/flanvotumab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Flanvotumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Khalil DN, et al. An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma. Clin Cancer Res. 2016 Nov 1;22 (21) :5204-5210.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
abx831237-01Flanvotumab
GTR18337758-01Flanvotumab Antibody
591867Flanvotumab (TYRP1)
MBS1563589-01Research Grade Flanvotumab
E55B0581Flanvotumab (Reference antibody)
ICH5553-20mgFlanvotumab Biosimilar - Research Grade
A2309-1mgFlanvotumab (Anti-TRP1 / TYRP1)
048326TRP1/TYRP1 (flanvotumab) discontinued
GTR18697585-01Flanvotumab Human Monoclonal Antibody
GTR18781357-01(Flanvotumab) Biosimilar Reference Antibody

Popular Products